Vaccines are a modern miracle, saving an estimated 154 million lives in the last half-century. Vaccine skepticism is a ...

‘It’s the craziest most unacceptable situation I’ve ever seen,’ the policy director of an Iran watchdog group shared on X. The Islamic Republic's former ambassador to Germany, Seyed Hossein Mousavian, ...

The UK is poised to become the first country in the world to launch a new payment model for antibiotics that could reverse decades of decline in the category. The Department of Health, NHS England ...

The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry. Herceptin’s main US patent expires this month ...

Roche revealed in its first-quarter results statement that giredestrant missed the mark in the phase 2 acelERA trial in advanced breast cancer, in what appears to be another blow to the emerging ...

Successful early asset development relies on considering the clinical, patient and commercial elements of value collectively, says Jason McDonough. One of the greatest challenges in the early ...

Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs).

President Trump has withdrawn his nomination of Dave Weldon to lead the CDC, hours before he was to appear in front of a Senate confirmation hearing.

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study ...

Astellas has suffered another major setback with geographic atrophy (GA) treatment Izervay, this time in the US. The company has received a complete response letter (CRL) from the FDA for a ...

MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial.

President Trump has withdrawn his nomination of Dave Weldon to lead the CDC, hours before he was to appear in front of a Senate confirmation hearing.